Jefferies Maintains Hold on Bristol-Myers Squibb, Raises Price Target to $51
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Akash Tewari maintains a Hold rating on Bristol-Myers Squibb (NYSE:BMY) and raises the price target from $49 to $51.
August 28, 2024 | 6:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Akash Tewari maintains a Hold rating on Bristol-Myers Squibb and raises the price target from $49 to $51.
The increase in the price target from $49 to $51 by Jefferies suggests a slightly more positive outlook on Bristol-Myers Squibb's stock, which could lead to a modest upward movement in the stock price. However, the Hold rating indicates that the stock is expected to perform in line with the market.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100